Disease | acromegaly |
Symptom | C0346308|pituitary macroadenoma |
Sentences | 5 |
PubMedID- 22613412 | Objective: to investigate whether 3 months' preoperative treatment with lanreotide improved outcome in newly diagnosed patients with acromegaly resulting from invasive pituitary macroadenoma. |
PubMedID- 24062868 | pituitary macroadenoma presenting with pituitary apoplexy, acromegaly and secondary diabetes mellitus - a case report. |
PubMedID- 21099129 | Thirty-nine untreated acromegaly patients, all with invasive pituitary macroadenomas, were randomly divided into two groups: experimental group (n=19), and control group (n=20). |
PubMedID- 22564667 | A, contrast-enhanced sagittal mri of patient 3, a 19-yr-old male with extensive, heterogeneously enhancing fibrous dysplasia of the bones of the skull base (left panel, *), hypogonadism, hypothyroidism, and acromegaly associated with a multinodular pituitary macroadenoma occupying his sella turcica and extending intracranially into the interpeduncular cistern and behind the clivus (arrow in center panel). |
PubMedID- 21217906 | The patient was diagnosed to have intrasellar pituitary macroadenoma with acromegaly (clinically active disease) associated with secondary hypertension and diabetes mellitus and severe proliferative diabetic retinopathy. |
Page: 1